Stephen Squinto, Life Sciences Private Capital chief investment officer and managing partner
December 15, 2023 06:00 AM EST
People
Financing

Q&A: JP Mor­gan’s new life sci­ences pri­vate cap­i­tal leader on the bank’s ex­pand­ing am­bi­tions, vet­ting star­tups and Abu Dhabi’s biotech push

Amber Tong

Long­time biotech en­tre­pre­neur and in­vestor Stephen Squin­to helped build biotech gi­ants Re­gen­eron and Alex­ion be­fore mov­ing to the in­vest­ment world at Or­biMed Ad­vi­sors. Now, one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times